1/38
Looks like no tags are added yet.
4 unique bacterial species:
Actinomyces
Mycoplasma
Spirochetes
Chlamydia
Characteristics of actinomyces:
Gram positive
Branching filaments, resemble hyphae of fungi
Anaerobic, opportunistic
Normal flora of oral cavity
Where can A. isrealii be found?
in the oral cavity (normal flora)
Shape of A. israelii (actinomycosis):
Long branching filaments, similar to hyphae
This bacteria is:
Gram positive bacteria
has long branching filaments
Anaerobic, opportunistic
Part of normal flora
Actinomycetes (A. israelii)
Pathogenesis of actinomycosis:
Invades the submucosa, causing chronic inflammation
What is a distinctive feature of an actinomycosis infection?
Draining sinuses, sulfur granules
What are the sulfur granules made out of (actinomycosis)?
entangled conglomerate of bacteria
Immune cells cemented together by calcium and polysaccharide protein
What kind of progression is actinomycosis?
Fibrotic, slow progression
Clinical features of actinomyces:
Cervicofacial (lumpy jaw), 50%
Thoracic, abdominal, pelvic (IUD-associated), 50% between these sites
Brain abscesses possible
Chronic, draining lesions
Characteristics of this bacteria:
Gram-negative
Facultative aerobe, rod-shaped bacterium
In water and soil
Opportunistic pathogen, cause infections in immunocompromised patients
Hospital environments
Pseudomonas aeruginosa
Gram-positive or negative: Pseudomonas aeruginosa
gram-negative
Where is pseudomonas aeruginosa found?
soil and water
Shape of pseudomonas aeruginosa:
rod-shaped bacterium
Aerobe or anaerobe: Pseudomonas aeruginosa:
Aerobe, facultative
Motility of pseudomonas:
Polar flagella
The pseudomonas family can produce what pigments?
Pyocyanin (blue-green)
Pyoverdine (fluorescent)
Pseudomonas is a facultative aerobe, but is capable of anaerobic growth via:
nitrate reduction
Virulence factors of pseudomonas aeruginosa:
Adherence via pili and flagella to epithelial cells to non-biological surfaces
Biofilm matrix composed of alginate, polysaccharides
Biofilm aids in antibiotic tolerance and immune invasion
Virulence mechanisms of pseudomonas aeruginosa, toxins and enzymes:
Exotoxin A
Elastase and alkaline protease
Phospholipase C
Pyocyanin
Exotoxin A of pseudomonas aeruginosa:
ADP-ribosylates elongation factor 2, halting host protein synthesis
Elastase and alkaline of pseudomonas aeruginosa:
Degrade elastin and immunoglobulin
Phospholipase C of pseudomonas aeruginosa:
Disrupts cell membranes and surfactant in the lungs
Pyocyanin of psuedomonas aeruginosa:
induce oxidative stress and tissue necrosis
Virulence mechanisms of pseudomonas aeruginosa:
Type 3 secretion system (T3SS)
Type 3 Secretion System injects these effectors into host cells:
ExoS
ExoT
ExoU
ExoY
ExoU causes:
tissue necrosis
ExoS and T cause:
disruption of the actin cytoskeleton
A type 4 secretion system contributes to:
bacterial completion and persistence
How does pseudomonas respond to the immune system?
Inhibit neutrophil chemotaxis and phagocytosis through alginate shield
Degrade complement proteins and interferes with cytokine signaling
Chronic infection leads to chronic immune response, tissue remodeling
Pulmonary manifestation of pseudomonas:
Chronic colonization in cystic fibrosis
Ventilator-associated pneumonia
Skin/Soft tissue manifestation of pseudomonas:
Burn wound infections
Folliculitis
Ecthyma gangrenosum
Urinary tract manifestations of pseudomonas:
Urinary tract infections
Systemic manifestations of pseudomonas:
Bacteremia
Sepsis
(in immunocompromised patients, neutropenic patients)
Anti-biotic resistance of pseudomonas:
Low membrane permeability (intrinsic resistance)
Acquired resistance (Beta-lactamases, ESBLs, carbapenmases)
Biofilm-associated tolerance/quorum testing (adaptive resistance)
This bacteria is a major cause of nosocomal infections and health-care associated pneumonia, with a high morbidity in burn units, ICU’s, oncology wards and CF clinics.
Pseudomonas aeruginosa
If there is an increase in pseudomonas infections in a hospital, this may be indicative of:
a hospital water system contamination
How can pseudomonas be diagnosed in the lab?
Grow on blood and MacConkey agar, produce a specific pigment and smell
Oxidase positive, non-lactose fermenter
MALDI-TOF MS
PCR for virulence/resistance genes
Biofilm assays
How is pseudomonas treated?
Combo therapy with anti-pseudomonal beta-lactams, aminoglycosides, or fluoroquinolones
Novel agents like ceftolozane-taxobactam, cefiderocol
Experimental therapy (bacteriophage therapy), quorum-sensing inhibitors, anti-biofilm peptides